Healthcare - Medical - Devices - NYSE - US
$ 4.67
-2.51 %
$ 71.3 M
Market Cap
-2.48
P/E
CASH FLOW STATEMENT
-23.5 M
OPERATING CASH FLOW
-59 K
INVESTING CASH FLOW
28.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Owlet, Inc.
| Net Income | -32.9 M |
| Depreciation & Amortization | 2.21 M |
| Capital Expenditures | -59 K |
| Stock-Based Compensation | 9.93 M |
| Change in Working Capital | -4.82 M |
| Others | 3.65 M |
| Free Cash Flow | -23.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (32.9) | (79.3) | (71.7) | (10.5) | (17.9) |
| Depreciation & Amortization | 2.2 | 2.7 | 1.1 | 0.9 | 0.5 |
| Deferred Income Tax | 0 | 0 | (10.7) | 2.4 | 1.4 |
| Stock Based Compensation | 9.9 | 12.9 | 4.3 | 1.1 | 0.6 |
| Other Operating Activities | 2.1 | (2.4) | 26.8 | 0.4 | 0.3 |
| Change in Working Capital | (4.8) | (15.2) | 9.7 | 5.7 | 0.4 |
| Cash From Operations | (23.5) | (81.4) | (40.6) | (0.1) | (16.1) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 59 K | (1.6) | (2.0) | (1.1) | (1.6) |
| Other Items | 0 | 35 K | 20 K | 0 | (0.4) |
| Cash From Investing Activities | 59 K | (1.6) | (2.0) | (1.1) | (2.0) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0.2 | (1.5) | 4.0 | 6.3 | 8.6 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 57.2 | 0.6 | 116.6 | 0.1 | 3.9 |
| Cash From Financing Activities | 28.9 | (0.9) | 120.6 | 6.5 | 12.5 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 5.3 | (83.8) | 78.0 | 5.3 | 11.7 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (23.6) | (83.0) | (42.6) | (1.2) | (17.6) |